• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经核黄素和紫外线预冻病原体减少处理对保存在 AS-3 添加剂溶液中的解冻后红细胞的影响。

Effects of pre-freeze pathogen reduction with riboflavin and UV light on red cells stored post-thaw in AS-3 additive solution.

机构信息

Department of Hematology and Blood Transfusion, Military University Hospital, Prague, Czech Republic.

Department of Military Internal Medicine and Military Hygiene, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic.

出版信息

Transfusion. 2023 May;63(5):1067-1073. doi: 10.1111/trf.17313. Epub 2023 Mar 20.

DOI:10.1111/trf.17313
PMID:36938976
Abstract

BACKGROUND

Pathogen reduction technology (PRT) may improve the safety of RBCs for transfusion. As the Czech Republic considers PRT, we asked what effects riboflavin and UV light PRT pre-freezing has on the post-thaw recovery and properties of cryopreserved RBCs (CRBCs) after deglycerolization and liquid storage.

STUDY DESIGN AND METHODS

24 Group O whole blood (WB) units were leukoreduced and then treated with riboflavin and UV light PRT (Mirasol, Terumo BCT, USA) before cryopreservation (T-CRBC); 20 similarly-collected units were untreated controls (C-CRBC). Units were processed to RBCs and then cryopreserved with 40% glycerol (wt/vol), frozen at -80°C, stored >118 days, reconstituted as deglycerolized RBC units in AS-3, and stored at 4 ± 2°C for 21 days. One treated unit sustained massive hemolysis during the post-thaw wash process and was removed from data analysis. The remaining units were assessed pre-PRT, post-PRT, and post-thaw-wash on days 0, 7, 14, and 21 for hematocrit, volume, hemoglobin per transfusion unit, pH, % hemolysis, hemoglobin in the supernatant, potassium, phosphorus, NH , osmolality, ATP, and 2,3-diphosphoglycerate.

RESULTS

PRT with leukoreduction caused a 5% loss of RBC followed by a 24% freeze-thaw-wash related loss for a total 28% loss but treated units contained an average of 45 g of hemoglobin, meeting European Union guidelines for CRBC. T-CRBCs displayed higher post-wash hemolysis, potassium, and ammonia concentrations, and lower ATP at the end of storage.

CONCLUSIONS

Cryopreserved RBCs from Riboflavin and UV light-treated WB meet the criteria for clinical use for 7 days after thawing and provide additional protection against infectious threats.

摘要

背景

病原体减少技术(PRT)可能提高输血用红细胞的安全性。由于捷克共和国正在考虑 PRT,我们询问了在预冻前使用核黄素和紫外线 PRT 对解冻后恢复和甘油化后液态储存的冷冻保存红细胞(CRBC)的特性的影响。

研究设计和方法

24 个 O 型全血(WB)单位经过白细胞减少处理,然后用核黄素和紫外线 PRT(美国 Terumo BCT 的 Mirasol)进行冷冻保存前处理(T-CRBC);20 个相同采集的单位为未处理对照(C-CRBC)。单位被处理成 RBC 并在 40%甘油(重量/体积)中冷冻,在-80°C 下冷冻,储存>118 天,在 AS-3 中重建为去甘油化 RBC 单位,并在 4°C±2°C下储存 21 天。一个处理过的单位在解冻后清洗过程中发生严重溶血,从数据分析中删除。剩余的单位在 PRT 前、PRT 后和解冻后清洗后的第 0、7、14 和 21 天进行评估,用于评估红细胞比容、体积、每单位输血的血红蛋白、pH 值、%溶血、上清液中的血红蛋白、钾、磷、NH3、渗透压、ATP 和 2,3-二磷酸甘油酸。

结果

白细胞减少处理加上 PRT 导致 RBC 丢失 5%,随后冷冻-解冻-清洗损失 24%,总丢失率为 28%,但处理过的单位平均含有 45g 血红蛋白,符合欧盟对 CRBC 的指南。T-CRBC 在解冻后清洗后的溶血、钾和氨浓度较高,储存结束时 ATP 较低。

结论

从核黄素和紫外线处理的 WB 制备的冷冻保存 RBC 在解冻后 7 天内符合临床使用标准,并提供了对传染性威胁的额外保护。

相似文献

1
Effects of pre-freeze pathogen reduction with riboflavin and UV light on red cells stored post-thaw in AS-3 additive solution.经核黄素和紫外线预冻病原体减少处理对保存在 AS-3 添加剂溶液中的解冻后红细胞的影响。
Transfusion. 2023 May;63(5):1067-1073. doi: 10.1111/trf.17313. Epub 2023 Mar 20.
2
Assessing quality of blood components derived from whole blood treated with riboflavin and ultraviolet light and separated with a fully automated device.评估用核黄素和紫外线处理并通过全自动设备分离的全血制备的血液成分的质量。
Blood Transfus. 2022 Sep;20(5):395-403. doi: 10.2450/2022.0278-21. Epub 2022 Feb 1.
3
Cryopreservation of apheresis platelets treated with riboflavin and UV light.经核黄素和紫外线处理的单采血小板的冷冻保存。
Transfus Apher Sci. 2023 Apr;62(2):103580. doi: 10.1016/j.transci.2022.103580. Epub 2022 Sep 19.
4
Effect of cryopreservation on a rare McLeod donor red blood cell concentrate.冷冻保存对罕见的 McLeod 供者红细胞浓缩物的影响。
Immunohematology. 2021 Jun;37(2):78-83. doi: 10.21307/immunohematology-2021-012.
5
Prolonged post-thaw shelf life of red cells frozen without prefreeze removal of excess glycerol.在未预先冷冻去除多余甘油的情况下冷冻的红细胞解冻后保质期延长。
Vox Sang. 2015 Apr;108(3):219-25. doi: 10.1111/vox.12219. Epub 2014 Dec 4.
6
In vitro characteristics and in vivo platelet quality of whole blood treated with riboflavin and UVA/UVB light and stored for 24 hours at room temperature.经核黄素和 UVA/UVB 光处理并在室温下储存 24 小时的全血的体外特性和体内血小板质量。
Transfusion. 2021 Jul;61 Suppl 1:S101-S110. doi: 10.1111/trf.16500.
7
Red blood cells derived from whole blood treated with riboflavin and ultraviolet light maintain adequate survival in vivo after 21 days of storage.用核黄素和紫外线处理过的全血所产生的红细胞在储存21天后仍能在体内保持足够的存活率。
Transfusion. 2017 May;57(5):1218-1225. doi: 10.1111/trf.14084. Epub 2017 Mar 31.
8
The in vitro quality of red blood cells frozen with 40 percent (wt/vol) glycerol at -80 degrees C for 14 years, deglycerolized with the Haemonetics ACP 215, and stored at 4 degrees C in additive solution-1 or additive solution-3 for up to 3 weeks.红细胞在-80℃下用40%(重量/体积)甘油冷冻14年,使用Haemonetics ACP 215进行去甘油处理,然后在4℃下于添加剂溶液-1或添加剂溶液-3中储存长达3周后的体外质量。
Transfusion. 2004 Jul;44(7):990-5. doi: 10.1111/j.1537-2995.2004.04001.x.
9
Use of supernatant osmolality and supernatant refraction to assess the glycerol concentration in glycerolized and deglycerolized previously frozen RBC.使用上清液渗透压和上清液折射法评估先前冷冻的甘油化和去甘油化红细胞中的甘油浓度。
Transfus Apher Sci. 2007 Apr;36(2):133-7. doi: 10.1016/j.transci.2006.11.002. Epub 2007 Mar 21.
10
A multicenter study of in vitro and in vivo values in human RBCs frozen with 40-percent (wt/vol) glycerol and stored after deglycerolization for 15 days at 4 degrees C in AS-3: assessment of RBC processing in the ACP 215.一项多中心研究:用40%(重量/体积)甘油冷冻人红细胞,并在去甘油后于4℃在AS-3中储存15天的体外和体内值评估:ACP 215中红细胞处理的评估
Transfusion. 2001 Jul;41(7):933-9. doi: 10.1046/j.1537-2995.2001.41070933.x.